Corteva (NYSE:CTVA – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 4th. Analysts expect the company to announce earnings of $0.81 per share for the quarter. Corteva has set its FY22 guidance at $2.30-2.50 EPS.Investors interested in listening to the company’s conference call can do so using this link.
Corteva (NYSE:CTVA – Get Rating) last issued its quarterly earnings results on Wednesday, February 2nd. The company reported $0.08 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.08. Corteva had a net margin of 11.24% and a return on equity of 6.32%. The company had revenue of $3.48 billion during the quarter, compared to analysts’ expectations of $3.45 billion. During the same period last year, the company posted $0.04 EPS. Corteva’s revenue was up 8.5% on a year-over-year basis. On average, analysts expect Corteva to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Shares of NYSE CTVA opened at $56.63 on Wednesday. Corteva has a 1 year low of $40.60 and a 1 year high of $62.04. The stock has a market cap of $41.16 billion, a P/E ratio of 23.89, a price-to-earnings-growth ratio of 1.78 and a beta of 0.71. The firm has a 50-day moving average of $55.92 and a 200 day moving average of $49.97. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.63 and a quick ratio of 1.08.
In related news, Director Klaus A. Engel sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 15th. The shares were sold at an average price of $52.76, for a total value of $158,280.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Brian Titus sold 23,500 shares of the firm’s stock in a transaction that occurred on Friday, February 11th. The stock was sold at an average price of $51.53, for a total transaction of $1,210,955.00. The disclosure for this sale can be found here. Insiders own 0.08% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Chicago Partners Investment Group LLC boosted its holdings in shares of Corteva by 8.0% in the fourth quarter. Chicago Partners Investment Group LLC now owns 4,720 shares of the company’s stock worth $240,000 after buying an additional 350 shares during the last quarter. Horizon Investments LLC lifted its holdings in Corteva by 7.9% during the fourth quarter. Horizon Investments LLC now owns 5,509 shares of the company’s stock valued at $260,000 after purchasing an additional 403 shares in the last quarter. Kingsview Wealth Management LLC lifted its holdings in Corteva by 27.9% during the fourth quarter. Kingsview Wealth Management LLC now owns 8,039 shares of the company’s stock valued at $380,000 after purchasing an additional 1,754 shares in the last quarter. Integrated Wealth Concepts LLC lifted its holdings in Corteva by 19.4% during the fourth quarter. Integrated Wealth Concepts LLC now owns 12,639 shares of the company’s stock valued at $598,000 after purchasing an additional 2,054 shares in the last quarter. Finally, Boston Private Wealth LLC lifted its holdings in Corteva by 9.6% during the fourth quarter. Boston Private Wealth LLC now owns 25,702 shares of the company’s stock valued at $1,216,000 after purchasing an additional 2,258 shares in the last quarter. 78.44% of the stock is currently owned by institutional investors.
A number of research analysts recently issued reports on CTVA shares. Loop Capital raised shares of Corteva from a “hold” rating to a “buy” rating and set a $69.00 price target for the company in a research report on Thursday, April 14th. Mizuho raised their price objective on shares of Corteva from $55.00 to $60.00 in a research note on Friday, February 4th. Vertical Research lowered shares of Corteva from a “buy” rating to a “hold” rating and set a $58.00 price objective for the company. in a research note on Thursday, April 14th. KeyCorp raised their price objective on shares of Corteva from $58.00 to $63.00 and gave the company an “overweight” rating in a research note on Tuesday, April 5th. Finally, Zacks Investment Research upgraded shares of Corteva from a “sell” rating to a “hold” rating in a research note on Monday, February 7th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $56.86.
Corteva Company Profile (Get Rating)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
- Get a free copy of the StockNews.com research report on Corteva (CTVA)
- The Sherwin-Williams Company Bottoms Above Institutional Support
- Simpson Manufacturing Co. Hits The Nail On The Head, Again
- What To Make Of Activision Blizzard (NASDAQ: ATVI)
- Whirlpool Is A Steal At These Prices
- Kimberly-Clark Pops On Successful Price Pass-Through
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.